Novelis delivered strong quarter with record margins (with EBITDA/t at US$448) and healthy volume growth of 3%. However, headwinds on margins are clearly visible due to accentuating competition and contracting scrap spreads. Incrementally, impending acquisition of Aleris would deteriorate earnings and B/S quality due to its cyclical portfolio, peaked-out margins and...